CG PHARMACEUTICALS
DEAD

Serial Number

97270460

Owner

CG Pharmaceuticals, Inc

Attorney

Chang Sik Lim

Filing Date

Feb 16, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CG PHARMACEUTICALS Trademark

Serial Number: 97270460

CG PHARMACEUTICALS is a trademark filed by CG Pharmaceuticals, Inc on February 16, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

CG Pharmaceuticals, Inc (3 trademarks)

4 Orinda Way, Suite 100-D
Orinda, CA 94563

Entity Type: 03

Trademark Details

Filing Date

February 16, 2022

Registration Date

Not Registered

Published for Opposition

August 8, 2023

Goods & Services

Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; Providing information regarding medical conditions; medical information services; providing medical information regarding testing, diagnosis, and treatment of diseases; providing medical information to patients regarding disease management and medication

biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; biologic preparations for the treatment of cancer; biologic preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations and substances for use in oncology treatment; pharmaceuticals for the treatment of cancer; prescription pharmaceuticals for treatment of diseases and disorders, namely, cancer and chronic diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 3, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 3, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2025 EXRA
SOU EXTENSION 3 GRANTED
Apr 3, 2025 EX3G
SOU EXTENSION 3 FILED
Apr 2, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 1, 2024 EXRA
SOU EXTENSION 2 GRANTED
Oct 1, 2024 EX2G
SOU EXTENSION 2 FILED
Oct 1, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 1, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2024 EXRA
SOU EXTENSION 1 GRANTED
Apr 2, 2024 EX1G
SOU EXTENSION 1 FILED
Apr 2, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 2, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 3, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 8, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 8, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 19, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 2, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 1, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 1, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 30, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2022 NWOS
NEW APPLICATION ENTERED
Feb 19, 2022 NWAP